EXCEED THE SPACE PROVIDED. The overall working hypothesis of this proposal is that chronic alcohol consumption alters proteasome-dependent proteolytic activity of the liver, This decrease in activity contributes to the buildup of protein and impacts the degradation of modified proteins. Changes in the proteasome and/or ubiquitin-dependent proteolysis could be due to a number of factors. These include changes in the proteasome itself, changes in the level and composition of two regulatory complexes of the proteasome, the 19S and PA28 regulators, changes in accessory proteins that are required for the function of the proteasome such as organelle and cytosol specific chaperones, changes inubiquitin hydrolase activity, or changes in the susceptibility of proteins for degradation. It is possible that an inability to degrade modified protein permits CYP2El-hydroxyethyl radical adducts to be presented on the cell surface. CYP2E1 has also been suggested to be a source of active oxygen species in the liver so that the failure to degrade the protein could exacerbate oxidative stress initiated by Kupffer cells. The goals of the research described in this proposal are to characterize the proteasome-dependent degradative pathway after acute and chronic ethanol treatment, characterize the effect of ethanol on the degradation of endoplasmic reticulum proteins, and characterize the fate of proteins that become covalently modified by products of lipid peroxidation and/or ethanol metabolism. This will be accomplished using a combination of cell lines, primary hepatocytes, and whole animal studies. CYP2E1 will be used as a model for the degradation of an integral endoplasmic reticulum membrane protein. This enzyme also provides an excellent model to investigate the fate of a protein modified by ethanol metabolites. These goals will be attained with the following three specific aims: 1) Characterize the effect of ethanol on the activity of ubiquitin-dependent and independent degradation. Alterations in proteasome activity, location and interaction with the PA28nd 19S regulatory complexes will be monitored in livers from rats given ethanol intragastrically or in a Lieber-DeCarli liquid diet for 2, 4 and 6 weeks. 2) Determine whether the proteasome-dependent degradation of CYP2E1 requires the participation of ubiquitin, the 26S proteasome and/or specific chaperones. These studies will initially be conducted with CYP2E1 expressed in tet-HeLa cells. After the initial characterization with the transfected cell lines, similar analysis will be conducted with primary hepatocytes. 3) Characterize the fate of hydroxyethyl-modified CYP2E1 in cells in culture. These studies will determine whether cell surface expression is related to the original orientation of the enzyme in the endoplasmic reticulum. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AA008608-16
Application #
6865623
Study Section
Special Emphasis Panel (NSS)
Program Officer
Gentry, Thomas
Project Start
1991-09-25
Project End
2007-02-28
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
16
Fiscal Year
2005
Total Cost
$384,268
Indirect Cost
Name
Oregon Health and Science University
Department
Physiology
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Jones, Jeffrey P; Joswig-Jones, Carolyn A; Hebner, Michelle et al. (2011) The effects of nitrogen-heme-iron coordination on substrate affinities for cytochrome P450 2E1. Chem Biol Interact 193:50-6
Koop, Dennis R (2006) Alcohol metabolism's damaging effects on the cell: a focus on reactive oxygen generation by the enzyme cytochrome P450 2E1. Alcohol Res Health 29:274-80
Schattenberg, Jorn M; Wang, Yongjun; Rigoli, Raina M et al. (2004) CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling. Hepatology 39:444-55
DeBarber, Andrea E; Bleyle, Lisa A; Roullet, Jean-Baptiste O et al. (2004) Omega-hydroxylation of farnesol by mammalian cytochromes p450. Biochim Biophys Acta 1682:18-27
Huan, Jian-Ya; Streicher, John M; Bleyle, Lisa A et al. (2004) Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells. Toxicol Appl Pharmacol 199:332-43
Isayama, Fuyumi; Froh, Matthias; Bradford, Blair U et al. (2003) The CYP inhibitor 1-aminobenzotriazole does not prevent oxidative stress associated with alcohol-induced liver injury in rats and mice. Free Radic Biol Med 35:1568-81
Spatzenegger, Margit; Liu, Hong; Wang, Qinmi et al. (2003) Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling. J Pharmacol Exp Ther 304:477-87
Jones, Brett E; Liu, Hailing; Lo, Chau R et al. (2002) Cytochrome P450 2E1 expression induces hepatocyte resistance to cell death from oxidative stress. Antioxid Redox Signal 4:701-9
Wadsworth, T L; McDonald, T L; Koop, D R (2001) Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochem Pharmacol 62:963-74
Wadsworth, T L; Koop, D R (2001) Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chem Biol Interact 137:43-58

Showing the most recent 10 out of 30 publications